From: Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China
Year
DR-TB epidemiological parameter (all figures in thousands)
Incidence
Prevalence
Mortality
2020
69.9
218.9
30.6
2030
80.7
240.0
34.9
2040
91.0
260.7
38.6